Valuence Merger Corp. I (NASDAQ:VMCA) Short Interest Up 66.7% in August

Valuence Merger Corp. I (NASDAQ:VMCA) saw a large increase in short interest in August. As of August 31st, there was short interest totalling 500 shares, an increase of 66.7% from the August 15th total of 300 shares. Based on an average daily volume of 2,100 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the company’s stock are sold short.

Hedge Funds Weigh In On Valuence Merger Corp. I

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Berkley W R Corp bought a new position in shares of Valuence Merger Corp. I in the 1st quarter worth approximately $3,393,000. K2 Principal Fund L.P. purchased a new stake in Valuence Merger Corp. I in the 1st quarter worth approximately $1,670,000. Virtu Financial LLC purchased a new stake in Valuence Merger Corp. I in the 1st quarter worth approximately $357,000. Logan Stone Capital LLC purchased a new stake in Valuence Merger Corp. I in the 2nd quarter worth approximately $176,000. Finally, Condor Capital Management purchased a new stake in Valuence Merger Corp. I in the 2nd quarter worth approximately $171,000. Institutional investors own 52.21% of the company’s stock.

Valuence Merger Corp. I Price Performance

VMCA traded down $0.01 during midday trading on Friday, hitting $11.49. 15,502 shares of the company traded hands, compared to its average volume of 1,232. The company’s 50-day moving average is $11.50 and its 200 day moving average is $11.44. Valuence Merger Corp. I has a 52 week low of $10.95 and a 52 week high of $11.69.

Valuence Merger Corp. I (NASDAQ:VMCA) last posted its earnings results on Wednesday, August 14th. The company reported $0.02 earnings per share (EPS) for the quarter.

About Valuence Merger Corp. I

Valuence Merger Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in developing breakthrough technology in life sciences and/or advancing a platform for sustainable technology in Asia.